CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 83 filers reported holding CYTOSORBENTS CORP in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $13,000 | -45.8% | 10,129 | -8.0% | 0.00% | – |
Q2 2022 | $24,000 | -29.4% | 11,014 | +0.4% | 0.00% | – |
Q1 2022 | $34,000 | -32.0% | 10,969 | -8.8% | 0.00% | – |
Q4 2021 | $50,000 | -63.0% | 12,023 | -27.8% | 0.00% | – |
Q3 2021 | $135,000 | -4.9% | 16,659 | -12.0% | 0.00% | – |
Q2 2021 | $142,000 | -4.7% | 18,923 | +10.1% | 0.00% | – |
Q1 2021 | $149,000 | +9.6% | 17,185 | 0.0% | 0.00% | – |
Q4 2020 | $136,000 | -0.7% | 17,185 | 0.0% | 0.00% | – |
Q3 2020 | $137,000 | -12.2% | 17,185 | +8.9% | 0.00% | -100.0% |
Q2 2020 | $156,000 | +26.8% | 15,785 | -1.3% | 0.00% | 0.0% |
Q1 2020 | $123,000 | +101.6% | 15,985 | 0.0% | 0.00% | – |
Q4 2019 | $61,000 | -23.8% | 15,985 | 0.0% | 0.00% | – |
Q3 2019 | $80,000 | -32.2% | 15,985 | -11.1% | 0.00% | -100.0% |
Q2 2019 | $118,000 | -11.3% | 17,985 | +1.7% | 0.00% | 0.0% |
Q1 2019 | $133,000 | -10.1% | 17,685 | -4.1% | 0.00% | 0.0% |
Q4 2018 | $148,000 | -38.3% | 18,435 | -1.1% | 0.00% | 0.0% |
Q3 2018 | $240,000 | +20.6% | 18,635 | +6.9% | 0.00% | 0.0% |
Q2 2018 | $199,000 | – | 17,435 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skylands Capital, LLC | 1,126,300 | $8,706,000 | 1.93% |
Sargent Investment Group, LLC | 471,755 | $3,647,000 | 1.68% |
Manatuck Hill Partners, LLC | 125,000 | $966,000 | 0.89% |
Soleus Capital Management, L.P. | 69,600 | $538,000 | 0.63% |
EAM Investors, LLC | 136,098 | $1,052,000 | 0.33% |
Granahan Investment Management | 691,130 | $5,342,000 | 0.29% |
EAM Global Investors LLC | 61,795 | $478,000 | 0.28% |
Winning Points Advisors, LLC | 35,000 | $269,000 | 0.26% |
Leap Investments LP | 14,200 | $110,000 | 0.16% |
Avenir Corp | 150,600 | $1,164,000 | 0.16% |